Clifford M. Takemoto

Hematology | Oncology
400 N State Of Franklin Rd
Fl 1
Johnson City, TN 37604

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Journal: Blood
Published: May 14, 2026

Prevalence of Low Bone Mineral Density Increases With Age in Sickle Cell Disease.

Prevalence of Low Bone Mineral Density Increases With Age in Sickle Cell Disease.

Journal: EJHaem
Published: April 17, 2026

G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients.

G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients.

Journal: Clinical biochemistry
Published: February 10, 2026

A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial.

A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial.

Journal: Trials
Published: January 28, 2026

Neurocognitive and Academic Outcomes for Children With Sickle Cell Disease After Changes in Academic Instruction During the COVID-19 Pandemic.

Neurocognitive and Academic Outcomes for Children With Sickle Cell Disease After Changes in Academic Instruction During the COVID-19 Pandemic.

Journal: Pediatric blood & cancer
Published: January 05, 2026

The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney Function.

The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney Function.

Journal: American journal of hematology
Published: December 29, 2025

A novel US-based grading system for disease severity in sickle cell disease: the Sickle Cell Outcome Grading System (SCOGS).

A novel US-based grading system for disease severity in sickle cell disease: the Sickle Cell Outcome Grading System (SCOGS).

Journal: The Lancet. Haematology
Published: December 22, 2025

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

Journal: Blood advances
Published: December 16, 2025

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

Journal: Blood advances
Published: December 16, 2025

ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism.

ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism.

Journal: Blood advances
Published: December 16, 2025

Increased Prevalence of Clonal Hematopoiesis in Children with Sickle Cell Disease.

Increased Prevalence of Clonal Hematopoiesis in Children with Sickle Cell Disease.

Journal: Blood
Published: July 23, 2025

Increased prevalence of clonal hematopoiesis in children with sickle cell disease.

Increased prevalence of clonal hematopoiesis in children with sickle cell disease.

Journal: Blood
Published: July 23, 2025
Showing 1-12 of 93

Last Updated: 09/26/2026